RT Journal
A1 Giugliano GR, Schweiger MJ
T1 ONe can’t judge a stent by its cover
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2010
FD May 24
VO 170
IS 10
SP 915
OP 916
DO 10.1001/archinternmed.2010.145
UL http://dx.doi.org/10.1001/archinternmed.2010.145
AB 
The “law of unintended consequences” states that any purposeful action will produce some unintended consequences.1 The recent acquisition of the Guidant Corporation by Boston Scientific (BS) Corporation, Natick, Massachusetts, has led to policies that (1) promote wasteful spending and delay acquisition of necessary clinical information and (2) expose the interventional cardiology community to a potential appearance of conflict of interest at a time when physician-industry relationships are being carefully scrutinized.2- 4